This is not the most recent version of the article. View current version (4 FEB 2016)

Intervention Protocol

Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents

  1. Salima Punja1,
  2. Larissa Shamseer2,
  3. Lisa Hartling3,
  4. Liana Urichuk4,5,
  5. Ben Vandermeer3,
  6. Catherine J Nikles6,
  7. Sunita Vohra3,*

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 11 JUL 2012

DOI: 10.1002/14651858.CD009996


How to Cite

Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles CJ, Vohra S. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009996. DOI: 10.1002/14651858.CD009996.

Author Information

  1. 1

    University of Alberta, Department of Medicine, Edmonton, Alberta, Canada

  2. 2

    Ottawa Hospital Research Institute, Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa, Ontario, Canada

  3. 3

    University of Alberta, Department of Pediatrics, Edmonton, Alberta, Canada

  4. 4

    University of Alberta, Department of Psychiatry, Edmonton, Alberta, Canada

  5. 5

    Addiction and Mental Health, Alberta Health Services, Information & Evaluation Services, Edmonton, Alberta, Canada

  6. 6

    The University of Queensland, Department of Medicine, Ipswich, QLD, Australia

*Sunita Vohra, Department of Pediatrics, University of Alberta, Aberhart Centre One, Room 9424, 11402 University Avenue, Edmonton, Alberta, T6G 2J3, Canada. svohra@ualberta.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 11 JUL 2012

SEARCH

This is not the most recent version of the article. View current version (04 FEB 2016)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of amphetamines for ADHD in children and adolescents.